Basel Medical Group Ltd Ordinary Shares (BMGL) — Capital Reinvestment Ratio
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.51 Million) in capital expenditures ($7.92K). See Basel Medical Group Ltd Ordinary Shares balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Basel Medical Group Ltd Ordinary Shares Capital Reinvestment Ratio (2022–2024)
This chart tracks Basel Medical Group Ltd Ordinary Shares's Capital Reinvestment Ratio across 3 annual periods. Check Basel Medical Group Ltd Ordinary Shares (BMGL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Basel Medical Group Ltd Ordinary Shares (2022–2024)
Year-by-year Capital Reinvestment Ratio for Basel Medical Group Ltd Ordinary Shares from 2022 to 2024. For live market cap and broader valuation context, see BMGL market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.03x | $2.79 Million | $88.50K | — |